Dr. Reddy’s Laboratories holds 42nd annual shareholder meeting via videoconference

• Dr. Reddy’s held its 42nd annual general meeting on July 23, 2026.
• Shareholders adopted the audited standalone and consolidated financial statements for the year ended March 31, 2026.
• A final dividend of INR 8 per equity share was declared for the year ended March 31, 2026.
• Investors backed the re-appointment of K Satish Reddy as a director.
• Other resolutions passed included appointing Deloitte Haskins & Sells as statutory auditor, director appointments, and cost auditor remuneration ratification.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dr. Reddy's Laboratories Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001575872-26-000530), on July 23, 2026, and is solely responsible for the information contained therein.